Cytomegalovirus prophylaxis and treatment following bone marrow transplantation (Q38560786)

4 September 2017

1 reference

title

Cytomegalovirus prophylaxis and treatment following bone marrow transplantation (English)

1 reference

4 September 2017

0 references

A C Tsinontides

1

1 reference

PubMed ID

8913411

4 September 2017

T P Bechtel

series ordinal

2

1 reference

PubMed ID

8913411

4 September 2017

language of work or name

English

0 references

publication date

1 November 1996

1 reference

Annals of Pharmacotherapy

4 September 2017

1 reference

4 September 2017

30

1 reference

4 September 2017

11

1 reference

4 September 2017

1277-1290

1 reference

Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program

4 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001113

Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001113

A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001113

Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001113

Reducing the Risk for Transfusion-transmitted Cytomegalovirus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001113

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001113

The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001113

Foscarnet nephrotoxicity: mechanism, incidence and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001113

Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001113

Prevalence of Resistance in Patients Receiving Ganciclovir for Serious Cytomegalovirus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001113

Ganciclovir sensitivity of cytomegalovirus at diagnosis and during treatment of cytomegalovirus pneumonia in marrow transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001113

Adverse effects of intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001113

Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001113

Cytomegalovirus (CMV)-Specific Intravenous Immunoglobulin for the Prevention of Primary CMV Infection and Disease after Marrow Transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001113

Ganciclovir for the treatment of cytomegalovirus gastroenteritis in bone marrow transplant patients. A randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001113

Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001113

Cytomegalovirus pneumonia: the use of ganciclovir in marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001113

Ganciclovir therapy in iatrogenically immunosuppressed patients with cytomegalovirus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001113

Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001113

Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001113

Treatment of Interstitial Pneumonitis Due to Cytomegalovirus with Ganciclovir and Intravenous Immune Globulin: Experience of European Bone Marrow Transplant Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001113

Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809603001113

10.1177/106002809603001113

21 January 2018

Identifiers

DOI

1 reference

4 September 2017

1 reference

PubMed ID

8913411